-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明，无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
Press Release: Fidmi Medical Launches U.S. Sales of Novel Low-Profile PEG Device and Raises $2.2 Million
Press Release: Fidmi Medical Launches U.S. Sales of Novel Low-Profile PEG Device and Raises $2.2 Million
Press Release: Fidmi Medical Launches U.S. Sales of Novel Low-Profile PEG Device and Raises $2.2 Million
Fidmi Medical Launches U.S. Sales of Novel Low-Profile PEG Device and Raises $2.2 Million
PR Newswire
CAESAREA, Israel, Oct. 11, 2021
CAESAREA, Israel, Oct. 11, 2021 /PRNewswire/ -- Fidmi Medical Ltd. (www.fidmimedical.com) has announced completion of a $2.2 million financing round and launched its FDA-cleared low-profile Percutaneous Endoscopic Gastrostomy (PEG) device in the U.S. Investors in the round include leading medical technology company Micro-Tech (Nanjing) Co., Ltd. (688029: Shanghai), The Trendlines Group (www.trendlines.com), (SGX: 42T) (OTCQX: TRNLY), and Agriline. Micro-Tech has been named Fidmi's exclusive distributor in the U.S. (www.mtendoscopy.com) and China.
Gastrostomy tubes, which help patients receive long-term nutritional support, are typically placed endoscopically and are replaced every 3-6 months. Complications such as clogging and dislodgement are common, resulting in inadequate nutrition and medication delivery, numerous tube replacements, and hospitalizations, all at substantial cost to patients and the health care system.
Within this $800 million market, Fidmi Medical's innovative low-profile gastrostomy system can be utilized for both initial placement and replacement and is more durable and comfortable for patients. Fidmi's improved low-profile gastrostomy tube has a replaceable inner tube that can easily be changed by patients without the assistance of medical professionals and a highly stable internal bumper that is resistant to accidental dislodgement. These features are expected to result in fewer complications, reducing healthcare costs for payers and healthcare systems. The Fidmi PEGs will provide a substantial improvement in quality of life for patients and their caregivers.
Fidmi Medical CEO Shahar Millis remarked, "We are truly excited to embark on the market entry phase for Fidmi. With FDA clearance and strategic collaboration with Micro-Tech, a leader in this field, we are well-positioned to make a real difference for people requiring long-term nutritional support."
"Together, we saw the opportunity to distribute a device that positively impacts patients and helps them get back to living their lives. We worked quickly to align on a distribution plan that allows the system to be accessible by more physicians -- meeting their needs for more efficient and higher quality patient care, all while tangibly reducing the cost," said Chris Li, President of Micro-Tech Endoscopy USA. "We are proud to partner with Fidmi and applaud their success in improving patient quality of life."
About Fidmi Medical
Fidmi Medical is an Israeli medical device company dedicated to developing enhanced feeding devices that offer easy insertion, replacement, and removal. Fidmi is a portfolio company of The Trendlines Group.
About Micro-Tech Endoscopy USA
Micro-Tech Endoscopy is focused on creating top-quality products for endoscopic diagnosis, and therapeutic medical devices that allow physicians to provide the highest level of care. By partnering with doctors dedicated to innovation, Micro-Tech is committed to bringing better devices to market, with unparalleled speed, at an economical price, and without the burden of contracts.
Contact:
Fidmi Medical
Shahar Millis, CEO, Fidmi Medical Ltd.
info@fidmimedical.com
+972-77-3628362
Micro-Tech Endoscopy USA, Inc.
Stephanie Reynolds / Emmie McMinn
stephanie.reynolds@trailrunnerint.com
emmie.mcminn@trailrunnerint.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/fidmi-medical-launches-us-sales-of-novel-low-profile-peg-device-and-raises-2-2-million-301396871.html
SOURCE Fidmi Medical Ltd.
/Web site: https://www.fidmimedical.com
(END) Dow Jones Newswires
October 11, 2021 08:00 ET (12:00 GMT)
Press Release: Fidmi Medical Launches U.S. Sales of Novel Low-Profile PEG Device and Raises $2.2 Million
新闻稿：Fidmi Medical在美国推出新型低调PEG设备并筹集220万美元
Fidmi Medical Launches U.S. Sales of Novel Low-Profile PEG Device and Raises $2.2 Million
Fidmi Medical在美国推出新型低调PEG设备并筹集220万美元
PR Newswire
美通社
CAESAREA, Israel, Oct. 11, 2021
以色列凯撒利亚，2021年10月11日
CAESAREA, Israel, Oct. 11, 2021 /PRNewswire/ -- Fidmi Medical Ltd. (www.fidmimedical.com) has announced completion of a $2.2 million financing round and launched its FDA-cleared low-profile Percutaneous Endoscopic Gastrostomy (PEG) device in the U.S. Investors in the round include leading medical technology company Micro-Tech (Nanjing) Co., Ltd. (688029: Shanghai), The Trendlines Group (www.trendlines.com), (SGX: 42T) (OTCQX: TRNLY), and Agriline. Micro-Tech has been named Fidmi's exclusive distributor in the U.S. (www.mtendoscopy.com) and China.
亚洲网以色列凯撒利亚10月11日电Fidmi医疗有限公司(网址：www.fidmimedical.com)宣布完成一轮220万美元的融资，并在美国推出经食品和药物管理局批准的低调经皮内窥镜胃造口术设备。这轮融资的投资者包括领先的医疗技术公司微技(南京)有限公司(688029：上海)、趋势线集团(www.trendlines.com)、(新加坡证券交易所市场代码：42T)。Micro-Tech已被指定为Fidmi在美国(www.mtendosCopy.com)和中国的独家经销商。
Gastrostomy tubes, which help patients receive long-term nutritional support, are typically placed endoscopically and are replaced every 3-6 months. Complications such as clogging and dislodgement are common, resulting in inadequate nutrition and medication delivery, numerous tube replacements, and hospitalizations, all at substantial cost to patients and the health care system.
胃造瘘管帮助患者接受长期营养支持，通常放置在内窥镜下，每3-6个月更换一次。堵塞和移位等并发症很常见，导致营养和药物输送不足、大量更换管子和住院，所有这些都给患者和卫生保健系统带来了巨大的成本。
Within this $800 million market, Fidmi Medical's innovative low-profile gastrostomy system can be utilized for both initial placement and replacement and is more durable and comfortable for patients. Fidmi's improved low-profile gastrostomy tube has a replaceable inner tube that can easily be changed by patients without the assistance of medical professionals and a highly stable internal bumper that is resistant to accidental dislodgement. These features are expected to result in fewer complications, reducing healthcare costs for payers and healthcare systems. The Fidmi PEGs will provide a substantial improvement in quality of life for patients and their caregivers.
在这个8亿美元的市场中，Fidmi Medical的创新低调胃造口术系统可以用于初始放置和替换，对患者来说更耐用和舒适。Fidmi改进的低调胃造口管有一个可更换的内管，患者无需医疗专业人员的帮助就可以很容易地更换内管，以及一个高度稳定的内部保险杠，可以防止意外移位。这些功能预计将减少并发症，降低支付者和医疗系统的医疗成本。Fidmi钉子将大大提高患者及其照顾者的生活质量。
Fidmi Medical CEO Shahar Millis remarked, "We are truly excited to embark on the market entry phase for Fidmi. With FDA clearance and strategic collaboration with Micro-Tech, a leader in this field, we are well-positioned to make a real difference for people requiring long-term nutritional support."
Fidmi Medical首席执行官沙哈尔·米利斯说：“我们真的很高兴能进入Fidmi的市场进入阶段。有了FDA的批准以及与该领域的领先者Micro-Tech的战略合作，我们处于有利地位，能够为需要长期营养支持的人带来真正的不同。”
"Together, we saw the opportunity to distribute a device that positively impacts patients and helps them get back to living their lives. We worked quickly to align on a distribution plan that allows the system to be accessible by more physicians -- meeting their needs for more efficient and higher quality patient care, all while tangibly reducing the cost," said Chris Li, President of Micro-Tech Endoscopy USA. "We are proud to partner with Fidmi and applaud their success in improving patient quality of life."
美国微技内窥镜公司总裁克里斯·李说：“我们一起看到了分销一种对患者产生积极影响并帮助他们重新开始生活的设备的机会。我们迅速制定了一项分销计划，让更多的医生能够使用该系统，满足了他们对更高效、更高质量的患者护理的需求，同时切实降低了成本，”美国微技内窥镜公司总裁克里斯·李(Chris Li)说。我们为能与Fidmi合作感到自豪，并为他们在提高患者生活质量方面取得的成功而喝彩。“
About Fidmi Medical
关于菲德米医疗公司
Fidmi Medical is an Israeli medical device company dedicated to developing enhanced feeding devices that offer easy insertion, replacement, and removal. Fidmi is a portfolio company of The Trendlines Group.
Fidmi Medical是一家以色列医疗设备公司，致力于开发易于插入、更换和取出的增强型喂养设备。Fidmi是Trendines Group的投资组合公司。
About Micro-Tech Endoscopy USA
关于MicroTech内窥镜检查使用情况
Micro-Tech Endoscopy is focused on creating top-quality products for endoscopic diagnosis, and therapeutic medical devices that allow physicians to provide the highest level of care. By partnering with doctors dedicated to innovation, Micro-Tech is committed to bringing better devices to market, with unparalleled speed, at an economical price, and without the burden of contracts.
微技内窥镜专注于为内窥镜诊断和治疗性医疗设备创造高质量的产品，使医生能够提供最高水平的护理。通过与致力于创新的医生合作，Micro-Tech致力于以无与伦比的速度、经济的价格和没有合同负担的方式将更好的设备推向市场。
Contact:
联系方式：
Fidmi Medical
菲德米医疗
Shahar Millis, CEO, Fidmi Medical Ltd.
Shahar Millis，Fidmi Medical Ltd.首席执行官。
info@fidmimedical.com
邮箱：info@fidmimedical.com
+972-77-3628362
+972-77-3628362
Micro-Tech Endoscopy USA, Inc.
美国微科内窥镜公司。
Stephanie Reynolds / Emmie McMinn
斯蒂芬妮·雷诺兹/艾米·麦克明
stephanie.reynolds@trailrunnerint.com
邮箱：stephanie.reynolds@trailrunnerint.com
emmie.mcminn@trailrunnerint.com
邮箱：emmie.mcminn@trailrunnerint.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/fidmi-medical-launches-us-sales-of-novel-low-profile-peg-device-and-raises-2-2-million-301396871.html
查看原创内容以下载multimedia:https://www.prnewswire.com/news-releases/fidmi-medical-launches-us-sales-of-novel-low-profile-peg-device-and-raises-2-2-million-301396871.html
SOURCE Fidmi Medical Ltd.
来源：Fidmi Medical Ltd.
/Web site: https://www.fidmimedical.com
网址：https://www.fidmimedical.com
(END) Dow Jones Newswires
(完)道琼通讯社
October 11, 2021 08:00 ET (12:00 GMT)
2021年10月11日东部时间08：00(格林尼治标准时间12：00)
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国，moomoo上的投资产品和服务由Moomoo Financial Inc.提供，一家受美国证券交易委员会（SEC）监管的持牌主体。 Moomoo Financial Inc.是金融业监管局（FINRA）和证券投资者保护公司（SIPC）的成员。
在新加坡，moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供，该公司受新加坡金融管理局（MAS）监管(牌照号码︰CMS101000) ，持有资本市场服务牌照 (CMS) ，持有财务顾问豁免（Exempt Financial Adviser）资质。本内容未经新加坡金融管理局的审查。
在澳大利亚，moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供，该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构（AFSL No. 224663）。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件，这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大，通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供，并受加拿大投资监管机构（CIRO）监管。
在马来西亚，moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供，该公司受马来西亚证券监督委员会（SC）监管(牌照号码︰eCMSL/A0397/2024) ，持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
风险及免责提示
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国，moomoo上的投资产品和服务由Moomoo Financial Inc.提供，一家受美国证券交易委员会（SEC）监管的持牌主体。 Moomoo Financial Inc.是金融业监管局（FINRA）和证券投资者保护公司（SIPC）的成员。
在新加坡，moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供，该公司受新加坡金融管理局（MAS）监管(牌照号码︰CMS101000) ，持有资本市场服务牌照 (CMS) ，持有财务顾问豁免（Exempt Financial Adviser）资质。本内容未经新加坡金融管理局的审查。
在澳大利亚，moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供，该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构（AFSL No. 224663）。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件，这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大，通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供，并受加拿大投资监管机构（CIRO）监管。
在马来西亚，moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供，该公司受马来西亚证券监督委员会（SC）监管(牌照号码︰eCMSL/A0397/2024) ，持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能，分享给你的好友吧